Enforced expression of hsa-miR-125a-3p in breast cancer cells potentiates docetaxel sensitivity via modulation of BRCA1 signaling

Biochemical and Biophysical Research Communications

Volumn 479, Issue 4, 2016, Pages 893-900

  Xu, Xin ^a   Lv, Yong gang ^a   Yan, Chang you ^b   Yi, Jun ^a   Ling, Rui ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

^b Xi'an Health Management Service Center   (China)

Author keywords

BRCA1; Breast cancer; Chemoresistance; Docetaxel; miRNAs

Indexed keywords

BRCA1 PROTEIN; DOCETAXEL; HSA MIR 125A 5P; MICRORNA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; ANTINEOPLASTIC AGENT; BRCA1 PROTEIN, HUMAN; MIRN125 MICRORNA, HUMAN; RNA; TAXOID;

3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER RESISTANCE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG SENSITIVITY; GENE REPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; MCF 7 CELL LINE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; ANTAGONISTS AND INHIBITORS; BREAST NEOPLASMS; DRUG RESISTANCE; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; GENETICS; MCF-7 CELL LINE; METABOLISM; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

3' UNTRANSLATED REGIONS; ANTINEOPLASTIC AGENTS; BASE SEQUENCE; BRCA1 PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG RESISTANCE, NEOPLASM; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; GENES, BRCA1; HUMANS; MCF-7 CELLS; MICRORNAS; RNA, NEOPLASM; SIGNAL TRANSDUCTION; TAXOIDS;

EID: 84991686274     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2016.09.087     Document Type: Article

References (34)

1. [1] Zhang, J., Su, B., Gong, C., Xi, Q., Chao, T., miR-214 promotes apoptosis and sensitizes breast cancer cells to doxorubicin by targeting the RFWD2-p53 cascade. Biochem. Biophys. Res. Commun. 478 (2016), 337–342.
2. [2] Zhang, X., Zhong, S., Xu, Y., Yu, D., Ma, T., Chen, L., Zhao, Y., Chen, X., Yang, S., Wu, Y., Tang, J., Zhao, J., MicroRNA-3646 contributes to docetaxel resistance in human breast cancer cells by GSK-3beta/beta-Catenin signaling pathway. PLoS One, 11, 2016, e0153194.
3. [3] Yu, L., Su, Y.S., Zhao, J., Wang, H., Li, W., Repression of NR4A1 by a chromatin modifier promotes docetaxel resistance in PC-3 human prostate cancer cells. FEBS Lett. 587 (2013), 2542–2551.
4. [4] Wang, J., Yang, M., Li, Y., Han, B., The role of MicroRNAs in the chemoresistance of breast cancer. Drug Dev. Res. 76 (2015), 368–374.
5. [5] Singh, R., Mo, Y.Y., Role of microRNAs in breast cancer. Cancer Biol. Ther. 14 (2013), 201–212.
6. [6] Fan, Z., Cui, H., Yu, H., Ji, Q., Kang, L., Han, B., Wang, J., Dong, Q., Li, Y., Yan, Z., Yan, X., Zhang, X., Lin, Z., Hu, Y., Jiao, S., MiR-125a promotes paclitaxel sensitivity in cervical cancer through altering STAT3 expression. Oncogenesis, 5, 2016, e223.
7. [7] O'Day, E., Lal, A., MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res., 12, 2010, 201.
8. [8] Scata, K.A., El-Deiry, W.S., p53, BRCA1 and breast cancer chemoresistance. Adv. Exp. Med. Biol. 608 (2007), 70–86.
9. [9] Crown, J., O'Shaughnessy, J., Gullo, G., Emerging targeted therapies in triple-negative breast cancer. Ann. Oncol. 23:Suppl 6 (2012), vi56–65.
10. [10] McGrogan, B.T., Gilmartin, B., Carney, D.N., McCann, A., Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 1785 (2008), 96–132.
11. [11] Min, W., Wang, B., Li, J., Han, J., Zhao, Y., Su, W., Dai, Z., Wang, X., Ma, Q., The expression and significance of five types of miRNAs in breast cancer. Med. Sci. Monit. Basic Res. 20 (2014), 97–104.
12. [12] Ning, P., Zhong, J.G., Jiang, F., Zhang, Y., Zhao, J., Tian, F., Li, W., Role of protein S in castration-resistant prostate cancer-like cells. Endocr. Relat. Cancer 23 (2016), 595–607.
13. [13] Zhang, S., Li, W., Zhu, C., Wang, X., Li, Z., Zhang, J., Zhao, J., Hu, J., Li, T., Zhang, Y., Sertoli cell-specific expression of metastasis-associated protein 2 (MTA2) is required for transcriptional regulation of the follicle-stimulating hormone receptor (FSHR) gene during spermatogenesis. J. Biol. Chem. 287 (2012), 40471–40483.
14. [14] Dong, Y.S., Hou, W.G., Li, Y., Liu, D.B., Hao, G.Z., Zhang, H.F., Li, J.C., Zhao, J., Zhang, S., Liang, G.B., Li, W., Unexpected requirement for a binding partner of the syntaxin family in phagocytosis by murine testicular Sertoli cells. Cell Death Differ. 23 (2016), 787–800.
15. [15] Zhang, C., Lai, J.H., Hu, B., Zhang, S., Zhao, J., Li, W., A chromatin modifier regulates Sertoli cell response to mono-(2-ethylhexyl) phthalate (MEHP) via tissue inhibitor of metalloproteinase 2 (TIMP2) signaling. Biochim. Biophys. Acta 1839 (2014), 1170–1182.
16. [16] Li, W., Zeng, Y., Zhao, J., Zhu, C.J., Hou, W.G., Zhang, S., Upregulation and nuclear translocation of testicular ghrelin protects differentiating spermatogonia from ionizing radiation injury. Cell Death Dis., 5, 2014, e1248.
17. [17] Liang, Y., Dong, Y., Zhao, J., Li, W., YES1 activation elicited by heat stress is anti-apoptotic in mouse pachytene spermatocytes. Biol. Reprod., 89, 2013, 131.
18. [18] Li, W., Fu, J., Zhang, S., Zhao, J., Xie, N., Cai, G., The proteasome inhibitor bortezomib induces testicular toxicity by upregulation of oxidative stress, AMP-activated protein kinase (AMPK) activation and deregulation of germ cell development in adult murine testis. Toxicol. Appl. Pharmacol. 285 (2015), 98–109.
19. [19] Ding, J., Wang, H., Wu, Z.B., Zhao, J., Zhang, S., Li, W., Protection of murine spermatogenesis against ionizing radiation-induced testicular injury by a green tea polyphenol. Biol. Reprod., 92, 2015, 6.
20. [20] Zhang, S., Zeng, Y., Qu, J., Luo, Y., Wang, X., Li, W., Endogenous EGF maintains Sertoli germ cell anchoring junction integrity and is required for early recovery from acute testicular ischemia/reperfusion injury. Reproduction 145 (2013), 177–189.
21. [21] Li, W., Wu, Z.Q., Zhao, J., Guo, S.J., Li, Z., Feng, X., Ma, L., Zhang, J.S., Liu, X.P., Zhang, Y.Q., Transient protection from heat-stress induced apoptotic stimulation by metastasis-associated protein 1 in pachytene spermatocytes. PLoS One, 6, 2011, e26013.
22. [22] Toh, Y., Pencil, S.D., Nicolson, G.L., A novel candidate metastasis-associated gene, mta1, differentially expressed in highly metastatic mammary adenocarcinoma cell lines. cDNA cloning, expression, and protein analyses. J. Biol. Chem. 269 (1994), 22958–22963.
23. [23] Feng, W., Deng, Y., Wu, J., Zhang, H., Liang, J., Xian, H., Yang, S., Overexpression of BRCA1 attenuates the sensitivity of PC9 cells to gefitinib. Int. J. Clin. Exp. Pathol. 8 (2015), 12869–12876.
24. [24] Riquelme, I., Letelier, P., Riffo-Campos, A.L., Brebi, P., Roa, J.C., Emerging role of miRNAs in the drug resistance of gastric cancer. Int. J. Mol. Sci., 17, 2016, 424.
25. [25] Kopczynska, E., Role of microRNAs in the resistance of prostate cancer to docetaxel and paclitaxel. Contemp. Oncol. Pozn. 19 (2015), 423–427.
26. [26] Jiang, L., Huang, Q., Zhang, S., Zhang, Q., Chang, J., Qiu, X., Wang, E., Hsa-miR-125a-3p and hsa-miR-125a-5p are downregulated in non-small cell lung cancer and have inverse effects on invasion and migration of lung cancer cells. BMC Cancer, 10, 2010, 318.
27. [27] Zhou, D.H., Wang, X., Feng, Q., EGCG enhances the efficacy of cisplatin by downregulating hsa-miR-98-5p in NSCLC A549 cells. Nutr. Cancer 66 (2014), 636–644.
28. [28] Jiang, L., Chang, J., Zhang, Q., Sun, L., Qiu, X., MicroRNA hsa-miR-125a-3p activates p53 and induces apoptosis in lung cancer cells. Cancer Invest. 31 (2013), 538–544.
29. [29] Borgan, E., Navon, R., Vollan, H.K., Schlichting, E., Sauer, T., Yakhini, Z., Lingjaerde, O.C., Sorlie, T., Borresen-Dale, A.L., Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol. Oncol. 5 (2011), 564–576.
30. [30] Harte, M.T., Gorski, J.J., Savage, K.I., Purcell, J.W., Barros, E.M., Burn, P.M., McFarlane, C., Mullan, P.B., Kennedy, R.D., Perkins, N.D., Harkin, D.P., NF-kappaB is a critical mediator of BRCA1-induced chemoresistance. Oncogene 33 (2014), 713–723.
31. [31] Ferroudj, S., Yildiz, G., Bouras, M., Iscan, E., Ekin, U., Ozturk, M., Role of fanconi anemia/BRCA pathway genes in hepatocellular carcinoma chemoresistance. Hepatol. Res., 2016 Feb 16, 10.1111/hepr.12675 [Epub ahead of print].
32. [32] Almeida, L.O., Abrahao, A.C., Rosselli-Murai, L.K., Giudice, F.S., Zagni, C., Leopoldino, A.M., Squarize, C.H., Castilho, R.M., NFkappaB mediates cisplatin resistance through histone modifications in head and neck squamous cell carcinoma (HNSCC). FEBS Open Bio. 4 (2014), 96–104.
33. [33] Reid, L.J., Shakya, R., Modi, A.P., Lokshin, M., Cheng, J.T., Jasin, M., Baer, R., Ludwig, T., E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc. Natl. Acad. Sci. U. S. A. 105 (2008), 20876–20881.
34. [34] Czerwinska, P., Kaminska, B., Regulation of breast cancer stem cell features. Contemp. Oncol. Pozn. 19 (2015), A7–A15.